Is Turmeric Dangerous for your Kidneys?
Turmeric Scientific Name: Curcuma longa, Curcuma domestica
Common Name: Indian saffron, Curcumin Jiang huang
Turmeric is a plant prevalent in South Asia and cultivated in tropical areas. Curcumin is the active substance in turmeric. Curcumin represents between 2 and 8 % of most turmeric preparation, and it is the component that gives turmeric its yellow-orange color and flavor.
Benefits of turmeric
Curcumin/Turmeric has been used for its anti-inflammatory, anti-tumor, and antioxidant effects. It has also described some benefits for memory, arthritis, and cancer prevention. Some studies even found that it was safe and as effective as Tylenol or a non-steroidal anti-inflammatory drug (NSAID) to treat osteoarthritis of the knee. Turmeric could also help with premenstrual pain or headaches.
It is important to note that herbs and supplements could benefit some humans with certain specific issues while they are harmful for others.
Turmeric used as a spice or herb in food has been considered safe. Herbal supplements are more potent than herbs you would use in cooking. Hence it is essential to assess if such supplements are safe for you. It is important to note that not all "natural" products, plants, or even vitamins are harmless. Understanding how turmeric acts within the body and how these reactions can create positive or negative reactions, depending on the person or the presence of the balances/imbalances.
Turmeric and Oxalate
Turmeric is high in oxalate. Oxalate (also known as oxalic acid) is a compound in plants and a waste product our bodies produce. Various foods high in oxalate can also benefit our health, like leafy greens and legumes; again, oxalate is not bad for all. However, it could increase the risk of kidney stones, especially if you are prone to such. It has been found that the amount of oxalate excreted in urine plays an important role in calcium oxalate stone formation in the kidneys. Oxalate can also bind to magnesium, which can lead to magnesium deficiency.
Turmeric and COX-2 inhibitor
Turmeric is a COX-2 inhibitor, which means it blocks the action of the COX-2 enzyme. This enzyme is responsible for inflammation, so blocking this enzyme leads to an anti-inflammatory effect. At first glance, this seems great and beneficial. However, inflammation is not a root cause of issues, and taking turmeric long-term could be compared to taking a small anti-inflammatory dose of an NSAID drug, such as Advil®, Aspirin® or Celebrex®. We can now understand the possible adverse effects of turmeric, being heartburn, diarrhea, and increased risk of bleeding or kidney stones.
Remember that we cannot only look at the human body in one silo. While turmeric can have these adverse effects, other reactions within the body compensate or seem stronger since it can also lead to reduced blood sugar or blood pressure. The effect of turmeric may depend on the dose, duration, quality of the product, etc.
Who should avoid turmeric
You should be precautious with turmeric or speak with a healthcare provider before trying turmeric if:
You have gastrointestinal issues, such as irritable bowel disease, Crohn's disease, or Ulcerative Colitis);
If you have heartburn or acid reflux;
If you are known for having gallstones or kidney stones;
If you take blood thinner medication such as Coumadin®, Aspirin®, Xarelto®, or others;
If you take NSAID drugs or Acetaminophen®;
If you are undergoing chemotherapy, turmeric can interact with some chemotherapy protocols;
If you are taking Prograf®, as turmeric can increase its adverse effects;
Again, it doesn't mean it's a bad spice, but you would not want to double the effects and bring more imbalances to your health. The ideal would be to work with a healthcare provider to adjust your current drugs (if you take any) if ever you wish to take such a product.
Always share to your healthcare providers the dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.
References:
Bradford PG. Curcumin and obesity. Biofactors. 2013 Jan-Feb;39(1):78-87. doi: 10.1002/biof.1074. Epub 2013 Jan 22. PMID: 23339049.
Zhang, D. W., Fu, M., Gao, S. H., & Liu, J. L. (2013). Curcumin and diabetes: a systematic review. Evidence-based complementary and alternative medicine : eCAM, 2013, 636053. https://doi.org/10.1155/2013/636053
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer research and treatment, 46(1), 2–18. https://doi.org/10.4143/crt.2014.46.1.2
Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, Holmes RP. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413. doi: 10.1152/ajprenal.00373.2018. Epub 2018 Dec 19. PMID: 30566003; PMCID: PMC6459305.
Rushton HG, Spector M. Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats. J Urol. 1982 Mar;127(3):598-604. doi: 10.1016/s0022-5347(17)53920-8. PMID: 7062446.
P. C. Hallson, G. A. Rose, S. Sulaiman; Magnesium Reduces Calcium Oxalate Crystal Formation in Human Whole Urine. Clin Sci (Lond) 1 January 1982; 62 (1): 17–19. doi: https://doi.org/10.1042/cs0620017
Gene Bruno, MS, MHS – Dean of Academics, Huntington College of Health Sciences. Herbal Cox-2 inhibitors, 2009. Consulted March 13 2022.
Ferraro, P. M., Taylor, E. N., Gambaro, G., & Curhan, G. C. (2018). Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis, 46(3), 265–270. https://doi.org/10.1007/s00240-017-0999-5
Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012 Apr;45(4):221-6. doi: 10.5483/bmbrep.2012.45.4.221. PMID: 22531131.
Seehofer D, Schirmeier A, Bengmark S, et al. Inhibitory effect of curcumin on early liver regeneration following partial hepatectomy in rats. J Surg Res. Aug 2009;155(2):195-200.
Yun JM, Jialal I, Devaraj S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. May 2011;22(5):450-458.
Jantan I, Bukhari SN, Lajis NH, et al. Effects of diarylpentanoid analogues of curcumin on chemiluminescence and chemotactic activities of phagocytes. J Pharm Pharmacol. Mar 2012;64(3):404-412.
Chang KW, Hung PS, Lin IY, et al. Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer. Jul 1 2010;127(1):9-20.
Siwak DR, Shishodia S, Aggarwal BB, et al. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer. Aug 15 2005;104(4):879-890.
Uddin S, Hussain AR, Manogaran PS, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene. Oct 27 2005;24(47):7022-7030.
Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. Apr 15 2007;67(8):3853-3861.
Selvendiran K, Ahmed S, Dayton A, et al. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biol Ther. Nov 1 2011;12(9):837-845.
Sreekanth CN, Bava SV, Sreekumar E, et al. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene. Jul 14 2011;30(28):3139-3152.
Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-kappaB pathway: an in-vitro study of lymphoma. Anticancer Drugs. Jan 23 2012.
Kunnumakkara AB, Diagaradjane P, Guha S, et al. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res. Apr 1 2008;14(7):2128-2136.
Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014 Mar 20;9:451-8.
Singhal S, Hasan N, Nirmal K, et al. Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol. Trials. 2021 Jan 30;22(1):105.
Wang Z, Jones G, Winzenberg T, et al. Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis : A Randomized Trial. Ann Intern Med. 2020 Dec 1;173(11):861-869.